China Pharma Holdings, Inc. (CPHI)
NYSEAMERICAN: CPHI · Real-Time Price · USD
0.192
+0.002 (1.00%)
At close: Nov 20, 2024, 4:00 PM
0.209
+0.017 (8.91%)
After-hours: Nov 20, 2024, 7:59 PM EST
China Pharma Holdings Revenue
China Pharma Holdings had revenue of $1.10M in the quarter ending September 30, 2024, a decrease of -39.00%. This brings the company's revenue in the last twelve months to $5.54M, down -28.76% year-over-year. In the year 2023, China Pharma Holdings had annual revenue of $7.01M, down -13.48%.
Revenue (ttm)
$5.54M
Revenue Growth
-28.76%
P/S Ratio
0.47
Revenue / Employee
$24,003
Employees
231
Market Cap
3.53M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 7.01M | -1.09M | -13.48% |
Dec 31, 2022 | 8.10M | -1.54M | -15.95% |
Dec 31, 2021 | 9.64M | -1.22M | -11.27% |
Dec 31, 2020 | 10.87M | -57.49K | -0.53% |
Dec 31, 2019 | 10.92M | -1.41M | -11.41% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
NovaBay Pharmaceuticals | 13.84M |
Genetic Technologies | 6.45M |
Aptorum Group | 431.38K |
Azitra | 97.50K |
Alaunos Therapeutics | 7.00K |
CPHI News
- 3 months ago - China Pharma Holdings, Inc. expects to launch its Dry Eye Disease Therapeutic Device in the first quarter of 2025 - PRNewsWire
- 9 months ago - China Pharma Holdings Inc. Announces 1-for-5 Reverse Stock Split - PRNewsWire
- 1 year ago - China Pharma Holdings, Inc. Announced the Completion of Third Party Testing of Dry Eye Disease Therapeutic Device - PRNewsWire
- 1 year ago - China Pharma's Candesartan Hypertension Product Passes the Quality and Efficacy Consistency Evaluation of Generic Drugs - PRNewsWire
- 1 year ago - China Pharma Holdings Inc. Announces 1-for-10 Reverse Stock Split - PRNewsWire
- 2 years ago - China Pharma Holdings, Inc. Announced the Launch of N95 Medical Protective Mask - PRNewsWire
- 2 years ago - China Pharma Holdings, Inc. Announced that several products are included in the Catalogue of Medicines for People Infected with COVID-19 - PRNewsWire
- 2 years ago - China Pharma Holdings, Inc. Announced the Acquisition of Dry Eye Disease Therapeutic Device Project - PRNewsWire